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Abstract
Background: Since the biological properties of propolis depend to the plants that can be found in a specific
region, propolis from unexplored regions attracts the attention of scientists. Ethanolic extract of Cameroonian
propolis (EEP) is used to treat various ailments including gynecological problems and amenorrhea. Since there
were no scientific data to support the above claims, the present study was therefore undertaken to assess estrogenic
properties of Cameroonian propolis.
Methods: To achieve our goal, the ability of EEP to induce MCF-7 cells proliferation in E-screen assay as well as to
activate estrogen receptors α (ERα) and β (ERβ) in cell-based reporter gene assays using human embryonic kidney cells
(HEK293T) transfected with ERs was tested. Further, a 3-day uterotrophic assay was performed and the ability of EEP to
alleviate hot flushes in ovariectomized adult rats was evaluated.
Results: In vitro, EEP showed an antiestrogenic activity in both HEK293T ER-α and ER-β cells. In vivo, EEP induced
a significant increase in a bell shape dose response manner of the uterine wet weight, the total protein levels in
the uterus, the uterine and vaginal epithelium height and acini border cells of mammary gland with the presence
of abundant eosinophil secretions. Moreover, EEP induced a significant decrease in the total number, average
duration as well as frequency of hot flushes after 3 days of treatment in rat (equivalent to a month in woman).
The dose of 150 mg/kg exhibited the most potent estrogenic effects among all the tested doses. The UPLC-HRMS
analysis showed the presence of caffeic acid derivatives and trirtepernoids in EEP, which are well known endowed with
estrogenic properties.
Conclusion: These results suggest that Ethanolic extract of Cameroonian propolis has estrogen-like effects in
vivo and may alleviate some menopausal problems such as vaginal dryness and hot flushes.
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Background
Hot flushes are the most disturbing and annoying symp-
tom associated with natural menopause or following oo-
phorectomy [1]. Also known as vasomotor symptoms, it
occurs in 80% of menopausal women [2]. Hot flush is
characterized by a sudden sensation of heat or burning
starting in the head or neck and passing over the entire
body. Hot flushes are not life-threatening but can nega-
tively affect life’s quality for many women by causing
sleep disturbances that often result in fatigue, irritability,
forgetfulness, and acute physical discomfort, with nega-
tive effects on daily activities and work [3]. In addition,
hot flushes may be associated with serious medical con-
ditions. Women with hot flushes may have an increased
risk of developing Alzheimer’s disease, a serious neuro-
degenerative disease, compared to women without hot
flushes [4]. Hormone Replacement Therapy (HRT) was
for a long time the treatment of choice for the manage-
ment of climacteric problems [5]. Although estrogen
therapy is effective in suppressing hot flushes, it is asso-
ciated with an increased risk of endometrial cancer, and
when combined with a progestin to prevent endometrial
hyperplasia, it increases long-term risk of cardiovascular,
cerebrovascular, and thromboembolic events [6]. This
has resulted in a search for HRT alternatives, and plant-
derived substances, so-called phytoestrogens have received
a great deal of attention due to its potential protective ef-
fects against cardiovascular diseases, osteoporosis and
hormone-dependent cancers [7, 8]. These compounds are
flavonoids, lignanes, chalcone, coumestane and erythroi-
dine alkaloids [9, 10] and are being increasingly promoted
as the safer “natural alternative” to HRT [11].
Propolis is a popular remedy in the folk medicine of
several countries and a raw material for numerous prep-
arations, health foods and beverages [12]. It is a strongly
adhesive natural mixture produced by honeybees (Apis
mellifera) from resin collected on buds, leaves and stem
barks of some plants, mixed with pollen as well as en-
zymes secreted from the saliva glands of bees [12–14].
Nowadays, more than 300 compounds, among which
flavonoids, terpenoids, steroids, sugars, vitamins and
amino acids have been detected in raw propolis and
many valuable biological activities have been attributed
to propolis [15, 16]. Varied properties of propolis have
contributed to its wide use in traditional medical prac-
tice and for commercial purposes [12, 13, 17]. Since the
biological properties of propolis depend on its chemical
composition which greatly varies according to the plants
that can be found in a specific region [13, 18, 19], prop-
olis from unexplored regions attracts the attention of
scientists in the search of new bioactive molecules [12].
The use of propolis in the treatment and prevention of
numerous diseases has been documented [20]. In
Cameroon, a natural product prepared as ethanolic
extract of propolis is used to treat wounds, burns respira-
tory and dental infections, stomach ulcer, diabetes, high
blood pressure as well as amenorrhea and gynecological
problems [21–23]. Although EEP is being used increas-
ingly in Cameroonian traditional system, there are many
of its pharmacological activities claimed that remain un-
proven. The available data on the characteristics of Cam-
eroonian propolis were the work of Mbawala et al.
[21, 24] and Seidel et al. [25] on the antimicrobial ac-
tivities of the ethanol extracts from two different regions
(see Table 1). Njintang et al. [23] reported the antiradical
activities of Cameroonian propolis. Moreover, there are
two reports concerning compounds isolated from Camer-
oonian propolis [26, 27]. However, there have not yet been
reports on estrogenic potential of Cameroonian propolis.
In the present study, estrogenic effects of Cameroonian
propolis sample collected from Meiganga locality of
Adamawa Region of Cameroon were assessed in vitro
in E-screen and cell-based reporter gene assays. In
vivo, a 3-day uterotrophic assay in ovariectomized
adult rats (a classical tool for the detection of estro-
genicity of chemicals) was used. Furthermore, its abil-
ity to alleviate hot flushes induced in ovariectomized
rats was assessed.
Methods
Chemicals and reagents
Mass Spectroscopy (MS) grade methanol, acetonitrile
(ACN), water and formic acid (FA) for UPLC–MS ana-
lyses were purchased from Sigma-Aldrich (Saint-Quentin
Fallavier, France). Estradiol valerate (Progynova® 2 mg) was
purchased from DELPHARM (Lille, France). Genistein
was obtained from “Extrasynthese®” (Genay, France). The
penicilline (xtapen®) was provided by CSPC Zhongnuo
pharmaceutical (Shijiazhuang City, China). The Diclofenac
(Dicloecnu®) was provided by ECNU pharmaceutical
(Yanzhou City, China). Serums and antibiotics were
purchased from GIBCO (Grand Island, NY). The
17β-estradiol benzoate [(Estr-1,3,5(10)-trien-3,16α,17β-
triol); purity ≥ 98%] was obtained from Sigma-Aldrich
(Hamburg, Germany). The 2-[4-(2-hydroxyethyl)pipera-
zin-1-yl]ethane sulfonic acid (HEPES, purity ≥ 99.5%) was
purchased from Ludwig Biotecnologia Ltda (Alvorada, RS,
Brazil). Trypan blue, Alamar blue, Sulforodamine B and
cell culture mediums were purchased from Sigma-Aldrich
(St. Louis, MO, USA). The Smart Button Data loggers
were purchased from ACR System Inc (Surrey, Canada).
Source and preparation of Cameroonian propolis
The propolis used in this study was harvested in Meiganga
locality of Adamawa Region in January 2013. The ethano-
lic extract of propolis was prepared as previously de-
scribed by Mbawala et al. [21] and Njintang et al. [23] and
stored under dry conditions at 4 °C until needed for
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analysis. Briefly, after drying and grinding, 62.5 g of dried
propolis were extracted with 150 mL of ethanol 70% (v/v)
at room temperature for 24 h. The ethanol suspension
was separate by centrifugation at 1000 rpm for 10 min at
room temperature, and the supernatant was poured in a
50 mL dark volumetric flask and the volume completed
with 70% ethanol. To achieve our experimental goal, 0.5 L
of EEP was lyophilized during 72 h (Christ Beta 1–8 K,
Bioblock scientific, Germany) to yield 20.22 g of a brown
powder. The extracts were stored under dry conditions at
4 °C until needed for analysis.
Determination of doses
The doses of administration were calculated based on
the posology prescribed for gynecological complaints
and amenorrhea: 2 tea spoons in ½ of glass water, 3
times a day. This was powdered by lyophilisation to af-
ford 0.4 g used for one person/day. Taking as average
Table 1 Recapitulative informations on propolis from Adamawa Region, Cameroon
Propolis samples (Year) Solvant of extraction (Yield) Phytochemical constituent Biological activities References
Propolis Meiganga
(2003 & 2005)
Ethanol (3.27%) Detection of phenolic compounds
with HPLC-PDA
Antibacterial activity against gram
positive bacteria. Relation between
phenolic compounds amount and
antibacterial activity.
[21, 24]
Propolis Meiganga
(2006)
Methanol (3.7%) lup-20(29)-en-3-one, lupeol,
erythrodiol palmitate, 18-iso-olean-
12-ene-3,11-dione, Caffeic acid
phenethyl ester (CAPE)
Antinociceptive activity of all the
three pentacyclic triterpenoids in the
test models of chemical nociception
and mechanical hypernociception
[26]
Propolis Meiganga
(2008)
Hexane (44.8%) Alkaloids, Coumarins, Steroids,
Triterpenes, Volatile, 2 compound
was not yet elucidated
Absence of antibacterial activity [27]
Propolis Meiganga
(2008)
Methanol (3.5%) Alkaloids, Reducing compounds,
Coumarins, Flavonoids, Saponins,
Tannins
Antibacterial activities; It was active
against Escherichia coli and
Pseudomonas aeruginosa
(MIC: 0.2 mg/ml)
[27]
Propolis Adamawa
(2013)
Acetone and
methanol (70%)
Terpenoids, phenolic acids, ursolic
acid, β-amyrin, Prenylated
phloroglucinone, cycloartenol
acetate
Phlorogucinonone was found to
possess the highest potency against
Trypanosoma brucei brucei
[52]
Propolis Adamawa
(2007)
Ethanol (missing data) Missing data Among all African propolis sample
tested, Cameroonian propolis was the
most potent.
[25]
Propolis Ngaoundal
(2011)
Ethanol (5.25%), methanol
(9%) and water (1.5%)
Volatile oils, Phenolic compounds,
Saponins, Reducing substances,
Coumarines, Flavonoids, Triterpenes,
Catechic tannins, Fatty acids.
All extracts contain phenolic
compounds and present antiradical
activities Antioxidant capacities: the
order of decreasing antiradical activity
is Water > Methanol > Ethanol
[26]
Propolis
Ngaoundere (2004)
Ethanol (missing data) Total polyphenols (mg/L) 10.99 ± 2.56;
Tannins (mg/L): 1.57 ± 1.62
The Cameroonians propolis exhibited
higher scavenging (antiradical activity
(%):83.4 ± 2.3); activity which could
justify their commercialisation and role
in the management of some chronic
diseases
[23]
Propolis
Ngaoundere (2003)
Ethanol (missing data) Total polyphenols (mg/L) 227.8 ± 36.0;
Tannins (mg/L): 16.3 ± 12.6
(PROMAX-C, 2003)
Total polyphenols (mg/L) 772.8 ± 270.2;
Tannins (mg/L): 453.8 ± 361.5 in
PROMAX-C of 2006
All PROMAX-C samples tested showed
evidence of radical scavenging properties
with values ranging from 28 to 70%.
Radical scavenging activity: Antiradical
activity (%):43.7 ± 13.8 for PROMAX-C
made in 2003 and Antiradical activity
(%):67.3 ± 3.0 for PROMAX-C made
in 2006.
[23]
Propolis
Meiganga (2005)
Ethanol (4%) Contains phenolic compounds Antibacterial activity against gram positive
bacterial strain tested except Enterococcus
faecalis
[21]
Propolis
Martap (2005)
Ethanol (3.5%) Most active than PROMAX-C from
Meiganga with a most higher
phenolic content
Antibacterial activity against gram positive
bacterial strain tested except Enterococcus
faecalis. This propolis was the most active
and content more phenolic compounds
than other tested propolis.
[21]
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weight per person 70 kg, the extrapolation gave 5 mg/kg
BW which was multiplied by 10 to give 50 mg/kg BW
considered as pharmacological dose. In order to obtain a
dose dependent effect, an intermediate dose of 150 mg/kg
and a high dose of 300 mg/kg were obtained by multiply-
ing the low dose by a factor of 3.
UPLC-HRMS analysis of EEP
The fingerprints were performed using an UPLC
Acquity system (Waters, Milford, MA, USA) to ensure a
high resolving power and a baseline separation of most
of the compounds in a reasonable separation time. All
separations were performed on an Acquity UPLC BEH
C18 column (100 mm × 2.1 mm I.D., 1.7 μm) at 25 °C
with a flow rate of 0.400 mL/min. A guard column
(5 mm × 2.1 mm, 1.7 μm) with the same stationary phase
was placed before the column. The mobile phase con-
sisted of water + 0.1% FA (solvent A) and ACN+ 0.1%
FA (solvent B) and was used in multistep gradient mode.
The gradient was operated as follow: isocratic 5% B for
0.5 min, 5 to 100% B for 17.5 min, and a final isocratic
step for 5 min at 100% B. The sample manager was
thermostated at 10 °C, and the injection loop was set at
0.5 μL. The HRMS and HRMS/MS data were acquired
with a mass range of 100–1500 m/z using a XEVO-
G2QTOF instrument (Waters). ESI conditions operated
in negative mode were as follow: source temperature
120 °C, desolvation temperature 500 °C; capillary voltage
1.5 KV, cone voltage 10 V. Nitrogen was used as a cone
(10 L/h) and desolvatation gases (1000 L/h). Lockspray
flow rate was set at 20 μL/min and lockspray capillary at
2.5 KV. For the HRMS/MS acquisitions, a method in-
cluding the detection (full scan) and fragmentation of
the most intense peaks per scan was used. Collision en-
ergy was varying from 10 to 35 V.
Experimental organisms
Cell lines and cell culture
The HEK293T — Human Embryonic Kidney 293 T cells
line that contain the SV40 large T-antigen were pur-
chased from ATCC (The Global Bioresource Center,
Australia). Luciferase reporter construct was kindly pro-
vided by Dr Simon Chu (Hudson Institute of Medical
Research, Australia). Cells were transfected using Lipo-
fectamine Reagent obtained from Invitrogen (Sydney,
Australia). The MCF7 — human ER-positive breast
adenocarcinoma cells was obtained from the Rio de Janeiro
Cell Bank (Federal University of Rio de Janeiro, Brazil).
HEK293T cells were cultured routinely in phenol red
DMEM-F12 medium containing 10% fetal calf serum
(FCS), while MCF-7 cells were cultured in RPMI-1640
medium supplemented with 10% fetal bovine serum
(FBS). All cell cultures were also supplemented with 100
U/mL penicillin, 100 μg/mL streptomycin and 10 mM
HEPES. The cell cultures were maintained at 37 °C in a
5% CO2 humidified atmosphere and pH 7.4. Every two
days, cells were passaged by removing 90% of the super-
natant and replacing it with fresh medium. In all in vitro
experiments, viable cells were checked at the beginning
of the experiment by Trypan Blue dye exclusion test.
Animals
Healthy juvenile female Wistar rats aged 3 months ( 150 g)
were obtained from the breeding facility of the Laboratory
of Animal Physiology, University of Yaounde I (Cameroon).
Animals were housed in clean plastic cages at room
temperature (around 25 °C) under natural illumination
(approx. 12 h light/dark). They had free access to a
standard soy-free rat chow and water ad libitum. The
composition of animal diet was: corn (36.7%), bone
flour (14.5%), wheat (36.6%), fish flour (4.8%), crushed
palm kernel (7.3%), sodium chloride (0.3%) and vita-
min complex (Olivitazol® - 0.01%).
Ethical consideration
Housing of animals and all experiments were approved by
the Cameroon Institutional National Ethic Committee,
which adopted all procedures recommended by the
European Union on the protection of animals used
for scientific purposes.
Study design
Cell viability assay
The Cytotoxicity of EEP was evaluated by Alamar Blue
(resazurin) assay, in MCF-7 and HEK293T cells. This
assay evaluates the mitochondrial production as a meas-
urement of cell viability. For this, a density of 1 × 104
cells/well was seeded in a 96-well plate in 100 μL of cul-
ture medium. After 24 h to permit their adhesion, cells
were exposed for 24 h to the propolis extract at con-
centrations ranging from 10−5 to 10−1 μg/mL and 10−8 to
10−5 μg/mL for HEK293T and MCF-7 cells, respectively.
Each experiment was performed in triplicate and repeated
three times.
Experiment 1: E-screen assay
The MCF-7 cells proliferation assay was performed as de-
scribed by Resende et al. [28]. Briefly, cells were trypsi-
nized and seeded in 24-well plates at an initial
concentration of 2 × 104 cells per well in RPMI supple-
mented with 10% FBS. After 24 h of incubation (37 °C, 5%
CO2) to permit their adhesion, cells were washed with
phosphate-buffered saline (PBS) and the Serum Replace-
ment 2 (0.5×) supplemented phenol red-free RPMI was
substituted for the seeding medium. EEP was added to the
experimental medium at concentrations from 1 × 10−8 to
1 × 10−5 μg/mL. For antiestrogenicity tests, before incuba-
tion, 1 × 10−8 M of 17β-estradiol was added to the wells.
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Cells treated with DMSO (0.01%) and 10% FBS in RPMI
were solvent and medium controls, respectively. The
steroid-free experimental medium serves as negative con-
trol while cells treated with 1 × 10−8 M of 17β-estradiol
was positive control. The assay was stopped after 144 h by
removing the medium from wells, fixing the cells with
cold 10% trichloracetic acid and incubated at 4 °C for 1 h.
Thereafter, cells were washed four times with tap water
and dried. Furthermore, cells were stained during 30 min
with 0.057% (w/v) sulforhodamine-B (SRB) dissolved in
1% acetic acid, rinsed four times with 1% acetic acid and
air dried. Bound dye was solubilized with 10 mM Tris
base (pH 10.5) in a shaker. Finally, aliquots were read in a
Biotek EL800 Multiscan apparatus (Winoosky, USA) at
510 nm. The estrogenic activity results were expressed as
mean ± standard error of mean (SEM) of the proliferative
effect (PE), which was calculated according to Schiliro´et
al. [29]: PE =max cell number of sample/cell number of
DMSO control. The estrogenic activity of a sample was de-
termined as the relative proliferative effect (RPE%). The
RPE compares the maximum proliferation induced by a
sample with that induced by 17β-estradiol: RPE%= [PE for
sample/PE for 17β-estradiol] × 100 [28].
Experiment 2: transfections and luciferase assays
The ability of EEP to activate α and β estrogen receptors,
in cell-based assays was tested. The Human Embryonic
Kidney 293 T cells (HEK293T) were transiently trans-
fected as previously described by Zingue et al. [30]. They
were then treated with different concentrations (from 10−5
to 10−1 μg/mL) of EEP for 24 h. Cells treated with E2
alone served as positive control. Reporter gene assays in
HEK293T-ERα cells and HEK293T-ERβ cells were
performed using a commercial kit (Promega, Australia)
according to the manufacturer’s instructions. Luciferase
activity was measured and normalised against β-
galactosidase activity determined by using the 2-
nitrophenyl β-D-galactopyranoside (ONPG) method
(Sigma-Aldrich, Sydney, Australia). Each experiment
was performed at least in duplicate and repeated three
times.
Experiment 3: the 3-day uterotrophic assay
Estradiol valerate, genistein and EEP were dissolved in
distilled water (dH2O) used as vehicle in this experi-
ment. Thirty female Wistar rats received a single intra-
muscular dose of long acting penicillin and diclofenac
(10 mg/kg and 3 mg/kg respectively) the day before
ovariectomy. Thereafter they were bilaterally ovariecto-
mized (OVX) using the dorsal approach under Diazepam
and ketamin anesthesia (respectively 10 mg/kg and
50 mg/kg BW; i.p.). Fourteen days after ovariectomy (time
necessary for endogenous hormonal decline), animals
were randomly distributed into 6 groups of five animals
each (n = 5) and treated once daily for 3 consecutive days
by gavage with 10 mL/kg of distilled water (OVX), 1 mg/
kg of estradiol valerate (E2V) and 10 mg/kg of genistein
(GEN). The remaining three groups received EEP at doses
of 50, 150 and 300 mg/kg BW. Twenty four hours after
the last administration, animals were sacrificed by decapi-
tation. Uteri were collected, trimmed of fat and wet
weighed. Uterus, vagina, and mammary gland were fixed
in 10% formalin for histological analyses. Estrogenic ef-
fects were evaluated based on uterine wet weight, the
uterine and vagina epithelial heights, total uterine protein
levels and mammary gland differentiation.
Experiment 4: measurement of hot flushes
The measurement of hot flushes have been made as pre-
viously described by Zingue et al. [30]. Data loggers were
used to monitor the core temperature changes in the an-
imals at 2 min intervals for 72 h and were preset to start
measuring core temperatures 12 h before the beginning
of the treatment until the end of treatment. A total of 35
acclimatized female rats were used in this experiment. A
4-cm long skin and abdominal musculature incisions
were made in the cote region of abdomen under valium
and ketamin anesthesia (respectively 10 and 50 mg/kg
BW; i.p.). A data logger protected in sterilized neutral
wax was placed in the abdominal cavity. Animals of
group 1 (n = 6) were considered as control sham-
operated (Sham) in which, the ovaries were exposed and
gently manipulated but not excised and the other 30 ani-
mal were ovariectomized (OVX) as described above. The
abdomen was closed with absorbable simple interrupted
sutures in the muscle layer and skin. Animals of group 1
received distilled water as vehicle, while the 30 ovariec-
tomized rats were randomly distributed into 6 groups of
5 animals each (n = 5) and treated for 3 days as de-
scribed above. Twenty four hours after the last adminis-
tration animals were sacrificed by decapitation, and the
data loggers recovered. Data (central body temperature)
was retrieved from loggers unto Excel spreadsheets and
analyzed using the ACR Trend Reader for Smart Button
Software. Substances were evaluated for their ability to
affect core temperature; an average core temperature
was calculated after every 6 h time point. The mean core
temperature change (Δ core temperature) was deter-
mined as previously described by Maswood et al. [31].
Hot flushes were considered for any internal tempera-
tures ≥ 38 °C. The total number of hot flushes, the average
of these hot flush durations and the frequency of hot
flushes were determined as described by Zingue et al. [30].
Histomorphological analysis
The formalin-fixed tissues were embedded in paraffin,
and sections of 5-μm thickness were cut. Following
hematoxylin-eosin staining, mammary gland differentiation,
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uterine and vaginal epithelial height were assessed on
microphotography using the complete Zeiss equipment
consisting of a microscope Axioskop 40 connected to a
computer where the image was transferred, and analyzed
with the MRGrab 1.0 and Axio Vision 3.1 softwares, all
provided by Zeiss (Hallbermoos, Germany).
Biochemical analysis
Uterine total protein levels were determined in uteri using
colorimetric methods described by Gonal et al. [32].
Statistical analysis
The data from each experimental group (n = 5) were
expressed as mean ± SEM. All graphs were plotted with
Sigma Prism 5.0. One-way analysis of variance (ANOVA)
followed by Dunnett’s test for multiple comparisons and
the Student’s t- test were used for statistical comparison
between different control and treated groups for in vivo
and in vitro experiments respectively. The significance of
the difference was fixed at p < 0.05.
Results
Phytochemical analysis
UPLC-HRMS analysis (Fig. 1 and Table 2) was carried
out to identify compound from ethanolic extract of
Cameroonian propolis. Briefly, all well resolved peaks in
BPI were selected and possible elemental compositions
(EC) were calculated. For reducing the possible EC
candidates, mass tolerance was set below 3 ppm, only C,
H, O and N were selected for calculations and only con-
sistent RDBeq values were considered. Additionally
HRMS/MS data as well as bibliographic information
were employed to identify the compounds. Furthermore
dimeric ions [2 M-H]− observed in case of triterpenoic
compounds supported the confirmation of EC for the
[M-H]− ion. The detected compounds of PROMAX-C
are summarised in Table 2 including their retention
time, EC, m/z (monoisotopic mass), RDBeq and their
major HRMS/MS fragments. Identified metabolites
are mainly caffeic acid derivatives and triterpenoids.
Indeed, diverse caffeic acid derivatives already de-
scribed in propolis extracts from Brazil and sub-
Saharan African countries [33, 34] have been detected
as caffeic acid 4-O-arabinoside (m/z = 311.0768), caffeic
acid 4-O-xyloside (m/z 311.0768), caffeoylquinic acid (m/
z = 353.0878), caffeic acid 4-O-glucoside (m/z = 341.0868)
and 3,4-dimethyl caffeic acid (m/z = 207.0656). Herein it
was not possible to distinguish caffeic acid 4-O-arabino-
side from caffeic acid 4-O-glucoside that is why they were
noted as caffeic acid pentoside. In addition, two others
common phenolic compounds in propolis were charac-
terised: coumaric acid (m/z = 163. 0386) and phloretic acid
(m/z = 165.0543) [14].
In addition several triterpenoids were well detected in
Cameroonian propolis and putative identification was
attempted comparing their ECs and fragmentation
Fig. 1 UHPLC–ESI-HRMS base peak chromatogram of EEP in the negative ionisation mode
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Table 2 Summary of compounds separated and identified in Cameroonian propolis by UHPLC-ESI-HRMS analysis in the negative ion
mode. Rt, [M-H]−, [2 M-H]−, EC and RDBeq information are given together with main fragments at MS/MS level
Pick
N°
Tr (min) [M-H]−
(m/z)
[2 M-H]−
(m/z)
EC Mass errors
(ppm)
RDBeq Fragment ions
(m/z)
Tentative identification References
1 2.30 311.0768 C14H15O8 0.3 7.5 137.0236
93.0335
caffeic acid 4-O-pentoside [33]
2 2.38 311.0768 C14H15O8 0.6 7.5 137.0236
93.0346
caffeic acid 4-O-pentosside [33]
3 2.60 341.0868 C15H17O9 1.5 7.5 167.0317 Caffeic acid 4-O-glucoside [33]
4 2.80 353.0878 C16H17O9 1.4 8.5 191.0558
173.0451
caffeoylquinic acid [34]
5 3.71 163.0386 C9H7O3 −5.5 6.5 Coumaric acid [14]
6 6.21 207.0656 C11H11O4 −0.5 6.5 3.4-Dimethyl caffeic acid (DMCA) [33]
7 6.26 165.0543 C9H9O3 −5.5 5.5 Phloretic acid [34]
8 10.332 477.3204 C28H45O6 −2.5 6.5 431.3155
415.2839
Terpenoid derivative
9 12.36 503.3375 C30H47O6 0.4 7.5 487.3423
441.3373
Triterpenoid
10 12.42 487.3424 C30H47O5 0.2 7.5 Triterpenoid
11 13.503 473.3275 C29H45O5 1.7 7.5 411.3252
325.1831
Triterpenoid
12 13.7 469.3315 C30H45O4 −0.6 8.5 415.3215
325.1845
Triterpenoid
13 13.82 487.3419 C30H47O5 −0.8 7.5 425.3147 Triterpenoid
14 14.399 485.3278 C30H45O5 2.3 8.5 471.3471
441.3362
Triterpenoid
15 14.57 487.3427 C30H47O5 0.8 7.5 459.347 Triterpenoid
16 15.01 485.3278 C30H45O5 0 8.5 433.3362
325.1843
Triterpenoid
17 15.07 471.3468 C30H47O4 0.5 7.5 453.3362
427.357
Maslinic or corosolic or
cycloanostoic acid derivatives
[13, 38]
18 15.374 469.3315 C30H45O4 −0.6 8.5 425.3418 Triterpenoid
19 15.857 299.2596 C18H35O3 0.3 1.5 3-hydroxystearic acid
20 16.2 431.3159 C27H43O4 −0.5 6.5 369.3164 Terpenoid derivative
21 16.40 455.3513 911.7104 C30H47O3 C60H95O6 −2.4 -2.7 7.5
13.5
Mangiferolic or isomangiferolic
acids
22 16.42 501.3576 C31H49O5 −0.8 7.5 Triterpenoid
23 16.46 469.3313 939.6696 C30H45O4 C60H91O8 −1.1
−2.7
8.5
13.5
Ambolic acid
24 16.63 453.3368 907.6818 C30H45O3 C60H91O6 −0.2
−0.2
8.5
15.5
Mangiferonic acid
25 16.91 471.347 943.7007 C30H47O4 C60H95O8 −0.8
−2.1
7.5
13.5
409.3465 Maslinic or corosolic or
cycloanostoic acid derivatives
[13, 38]
26 17.17 471.3467 C30H47O4 −0.4 7.5 455.3512
393.3148
Maslinic or corosolic or
cycloanostoic acid derivatives
[13, 38]
27 17.38 471.3467 C30H47O4 −0.8 7.5 409.347
393.3148
Maslinic or corosolic or
cycloanostoic acid derivatives
[13, 38]
28 17.96 455.3525 C30H47O3 −2 7.5 Mangiferolic or isomangiferolic
acids
29 18.02 457.3676 915.7413 C30H49O3 C60H99O6 −1.3
−2.1
6.5
11.5
457.3644 Ocotillone isomer [38]
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pathway with those reported in literature and databases
(Table 2). The detected triterpenoids exhibit the C30 skel-
eton characteristic of this family, the number of hydrogen
atoms was varying from 43 to 50, and the oxygen atom
numbers ranged from three to six. Concerning the frag-
mentation patterns, their HRMS/MS spectra were domi-
nated by typical neutral loss of 18, 28, 44 and 62 which
could be assigned to H2O, CO, CO2 and H2O +CO2, re-
spectively. It is worthwhile to note that these typical losses
have already been observed for triterpenoids fragmenta-
tion in negative mode using either ESI or Atmospheric
Pressure Photo Ionisation (APPI) sources [35, 36].
Among them, several triterpenoids were detected at m/
z = 455.3513 (C30H47O3) and m/z = 471.3468 (C30H47O4)
which corresponds to pentacyclic triterpenoids structure.
Some pseudo molecular ions could be attributed to triter-
penoids already found in Cameroonian propolis [37] such
as mangiferolic or isomangiferolic acids (m/z = 455.3513),
magiferonic acid (m/z = 453.3368) and ambolic acid (m/z
469.3315), while the ion at m/z = 471.3468 could be origi-
nated from maslinic and corosolic acids already detected
in Thai propolis [38] or cycloanostoic acid derivatives
from Cretan propolis [13]. Sanpa et al. [38] also idenfied
two isomers of ocotillone, tetracyclic triterpenoids, which
might correspond to the ion found at m/z = 457.3676.
Compound detected at m/z = 485.3278 (C30H45O5) share
same molecular formula than (24E)-3-oxo-27,28-dihy-
droxycycloart-24-en-26-oic acid found in propolis from
Burma [39]. Studying main fragment ions, it can be ob-
served formation of ion at m/z = 425.3418 (C30H49O) cor-
responding to derivatives of amyrin isomers or lupeol
mainly present in Cameroonian propolis [37]. However
data were not sufficient to confirm the structure of these
compounds and differentiate them.
In vitro estrogenicity assessment
Cytotoxicity
Ethanolic extract of propolis did not induced cytotoxic
effects in both MCF-7 and HEK293T cells at tested con-
centrations (Figs. 2a and 3a).
E-screen assay
Effects of EEP on MCF-7 cells proliferation are depicted
in Table 3 and Fig. 2. It can be observed that 17-β estra-
diol induced a significant (p < 0.001) increased of MCF-7
cells yield. EEP induced a significant (p < 0.05) increase
of MCF-7 cells yield only at the concentration of 0.1 μM
as compared to DMSO control. Further, a significant
and concentration-dependant antiestrogenic effect was
noted with EEP.
Transactivation assay
EEP activated ERα and ERβ at all tested doses, but it did
not exhibit agonistic activity (Fig. 3). Interestingly when
cotreated with E2, the high concentrations (0.01 and
0.1 μg/mL) of EEP significantly antagonized E2-activation
of both receptor subtypes.
In vivo estrogenicity assessment
Effects on the uterine wet weight and total protein levels in
uterine
As shown in Fig. 4a, a 3-day oral administration of EEP in-
duced a significant increase in the uterine wet weight and
total uterine protein levels at all tested doses in a bell
shape dose response. The maximum increase for these
two parameters was obtained at the dose of 150 mg/kg
BW (p < 0.01). However, this increase remained much
lower than in E2V-treated group.
Effects on the uterine epithelium
As depicted in Fig. 4c, following a 3-day treatment with
EEP, uterine epithelial height significantly increased by
58.5% (p < 0.05) only at dose of 150 mg/kg BW. However
these increases remained much lower than that induced
by E2V at the dose of 1 mg/kg BW, which showed a 3.5-
fold (p < 0.01) increase of uterine epithelial height but
seems to be higher than those induced by genistein
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Fig. 2 Effects of EEP on MCF-7 cells proliferation. Its effect was inves-
tigated by measuring E-screen assay. The relative MCF-7 cells yields
(PE) were measured in the presence of DMSO (0.01%), 17β-estradiol
(E2B, 10 nM) and EEP (PRO). PE =max cell number of sample/cell
number of DMSO control; * p < 0.05, *** p < 0.001 as compared to
the DMSO control
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(10 mg/kg). These effects were materialized in histo-
logical sections by an atrophic uterus with cuboidal
endometrial epithelium and loose connective tissue
composed of round nuclei in an unorganized pattern in
animals of OVX group. While in the E2V treated-group,
all structures are hypertrophic and hyperplastic; the
endometrium is multilayered with squamous metaplasia
and atypic mitotic figure surrounded by anaplastic
epithelial nuclei (Fig. 4d). Microphotographs of animals
that received EEP at the dose of 150 mg/kg displayed an
endometrium consisting of tall single-layered epithelial
cells with abundant mitotic figures and necrosis
(arrowhead), however, this effect is less than those observe
in E2V-treated group.
Effects on the vaginal epithelium
Figure 5 represents vaginal epithelial heights. The micro-
photographs of vaginal epithelium of the OVX group
showed an atrophic vaginal epithelium, consisting simply
of the stratum germinativum (Ge) which is composed of
a few layers of flattened cells (Fig. 5a). After genistein
(10 mg/kg) treatment, vaginal epithelium became hyper-
trophic and hyperplasic (Gr), with cornification (Co) in
the upper layers. While E2V (1 mg/kg) induced a
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Fig. 3 Effects of EEP on the activation of estrogen α and β receptors in HEK293T cells. The effect of EEP on estrogen α and β receptors activity in
the transiently transfected HEK293T-ERα and HEK293T-ERβ cells was investigated by measuring reporter gene-coupled luciferase activity. The relative
luciferase units (RLU) were measured in the presence of DMSO (0.1%), E2B (10 nM) and Cameroonian propolis; * p < 0.05, ** p < 0.01, *** p < 0.001 as
compared with control
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stronger hypertrophy and hyperplasia of vaginal epithe-
lium. EEP also induced hypertrophic and hyperplasic ef-
fects at all tested doses with cornification at the dose of
150 mg/kg. However compared to E2V there are less cell
layers and a lower degree of cornification.
The graphical representation of the vaginal epithelial
height (Fig. 5b) shows that E2V induced a 5-fold (p < 0.01)
increase of vaginal epithelial height. EEP significantly
(p < 0.01) and in the bell shaped dose response manner in-
creased vaginal epithelial height at all tested doses. The
maximum increment of 2.2-fold was obtained at the dose
of 150 mg/kg BW (from 4.06 ± 0.21 to 9.47 ± 1.07 μm) as
compared to the OVX group.
Effects on mammary glands
Figure 6 presents sections of mammary glands. Ovariec-
tomy induced an atrophy of mammary gland which is
materialized in OVX-histological section by a modest al-
veolar development, a small cluster of densely packed
epithelial cells without luminal formation are present in
the deep subcutaneous fat pad, the loss of the gland par-
enchyma (Tc) and the ductular and alveolar compo-
nents, while adipocyte tissue (At) appears prominent.
Mammary glands of genistein-treated group depict a few
terminal structures with small lumina with secretory
material; while mammary glands of E2V-treated group
present well-formed acinar and luminal structures, an
increase in proliferative activity compared to OVX group
such as increase of the diameter and the lumen of al-
veoli, abundant eosinophil secretion (Se) in lumen of al-
veoli and further compression of stromal fat. Similar
changes were noticed after a 3-days treatment with EEP
at all tested doses but only the dose of 150 mg/kg BW
presented an eosinophil secretion in their lumens.
Effects of EEP on hot flushes
Effect on core temperature
In Fig. 7, the result displayed shows that the OVX-
untreated group had an average core temperature higher
than those of sham operated group and all treated
groups (Fig. 7a and b). In this study, core temperature
peaked between 10:00 PM and 04:00 AM in all experi-
mental groups. Rats treated with standard drugs (E2V
and genistein) had lower temperature peaks compared
to the OVX animals (Fig. 7a). Similar changes were ob-
served following treatment with EEP at the dose of
150 mg/kg (Fig. 7b).
Figure 7c, d and Table 4 show the mean core
temperature changes. The mean and maximum core
temperature changes were significantly higher in OVX
group than normal animals (Sham) (p < 0.05) (Fig. 7c, d
and Table 4). E2V and genistein treatments significantly
reduced the core temperature changes as compared to
OVX group (p < 0.05). Importantly, EEP has significantly
reduced the core temperature changes (p < 0.05) at the
dose of 150 mg/kg) (Table 4).
Effects on total number and average duration of hot
flushes
If we consider any core temperatures ≥ 38 °C as hot
flushes, ovariectomy significantly increased the total
number of hot flushes in OVX animals as compared to
normal animals (Sham) (p < 0.01). E2V-treatment signifi-
cantly decreased the total number of hot flushes by
28.5% (from 29.4 ± 2.2 to 21.1 ± 2.42 hot flushes) as
compared to OVX group. Moreover, 3-days of oral ad-
ministration of EEP significantly reduced the total num-
ber of hot flushes by 21.8% at doses of 50 mg/kg and by
20.7% at the dose of 150 mg/kg BW (Fig. 8a).
Fourteen days after ovariectomy, the average duration of
hot flushes significantly increased in OVX animals as com-
pared to normal animals (Sham) (p < 0.001). Treatment
with estradiol (E2V) and genistein (GEN) significantly re-
duced this parameter (p < 0.01). The administration of EEP
induced a significant (p < 0.001) decrease in the average
duration of hot flushes only at doses of 150 mg/kg BW
(Fig. 8b).
Effects on frequency of hot flushes
All the studied groups presented a fluctuation in the
number of hot flushes by a 6 h period between high and
low values. Ovariectomy significantly increased the fre-
quency of hot flushes at 6 h intervals as compared to
normal group (Sham) (p < 0.01). More importantly, in
the meantime, values in OVX untreated animals were
much higher than for Sham operated and all treated
groups. As shown in Fig. 9, EEP at the dose of 150 mg/
kg BW significantly reduced (p < 0.01) the frequency of
hot flushes.
Table 3 Effects of EEP in MCF-7 cells proliferation assay
Group Concentration (μg/mL) PE RPE (%)
DMSO - 1 ± 0.03 47.17
E2B (10−8 M) 10−8 2.12 ± 0.13 100
Propolis 10−8 1.21 ± 0.15 57.07
10−7 1.32 ± 0.18 62.26
10−6 0.72 ± 0.08 33.96
10−5 0.48 ± 0.16 22.64
Propolis
+
E2B (10−8 M)
10−8 1.95 ± 0.03 91.98
10−7 1.72 ± 0.19 81.13
10−6 1.31 ± 0.06 61.79
10−5 1.21 ± 0.15 57.07
DMSO negative control, E2B Estradiol benzoate, served as positive control, PE
Proliferative effect calculated as the effect on solvent control, RPE Relative
proliferative effect, compares the maximum proliferation induced by a sample
with that induced by 17β-estradiol
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Discussion
Ethanolic extract of Cameroonian propolis is widely
used by Cameroonian population in folk medicine for
the treatment of multiple health problems, including
gynecological complaints and amenorrhea, which has
never been assessed scientifically. Previous reports show
that, components of propolis were qualitatively and
quantitatively variable, depending on the regional plant
ecology surrounding the bee hive. As depicted in Table 1,
analyses of numerous Cameroonian propolis samples
from Adamawa geographical zones display differences
on chemical composition, which in turn influences its
biological activity. It is well documented that phenolic
compounds constitute the most numerous group of
propolis components with respect to the quantity and
type out of which flavonoids are the most abundant [40].
Many scientific reports on Cameroonian propolis cor-
roborate this assertion and conclude that total polyphe-
nols contents in Cameroonian propolis fall within the
range of values reported for propolis from other coun-
tries [21, 24, 26, 27]. More precisely, Njintang et al. [23]
reported that the polyphenols content in PROMAX-C
samples varied from 186 to 1084 mg/L. This high vari-
ability of polyphenols amount in different propolis sam-
ples has been attributed to the change of regional plants
visited by honeybees. The phytochemical analysis
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Fig. 4 Effects of a 3-day treatment with EEP on the uterine wet weight (a), total protein levels in uterine (b), uterine epithelial height (c)
and microphotographs (d). OVX = OVX animals treated with the vehicle; E2V = OVX animals treated with estradiol valerate at 1 mg/kg BW;
GEN = OVX animals treated with genistein at 10 mg/kg BW; Propolis = OVX animals treated with EEP at doses of 50, 150 and 300 mg/kg
BW. *p < 0.05, **p < 0.01 as compared with control. Lu: uterine lumen; En: Endometrium; St: Stroma
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AB
Fig. 5 Effects of a 3-day treatment with EEP on the vaginal epithelium: microphotographs (a) and epithelial height (b). OVX = OVX animals treated
with the vehicle; E2V = OVX animals treated with estradiol valerate at 1 mg/kg BW; GEN = OVX animals treated with genistein at 10 mg/kg BW;
Propolis = OVX animals treated with EEP at doses of 50, 150 and 300 mg/kg BW. * p < 0.05, ** p < 0.01 as compared with control. Lv = vaginal
lumen, Co = stratum corneum, Gr = stratum granulosum, Ge = stratum germinativum, St: Stroma
Fig. 6 Effects of a 3-day treatment with EEP on mammary gland. OVX = OVX animals treated with the vehicle; E2V = OVX animals treated with
estradiol valerate at 1 mg/kg BW; GEN = OVX animals treated with genistein at 10 mg/kg BW; Propolis = OVX animals treated with EEP at doses of
50, 150 and 300 mg/kg BW. La = lumen of alveoli; Ep = aveoli epitheluim; At = adiposite tissue; Se = eosinophil secretion
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performed on Cameroonian propolis sample studied is
in agreement with previous reports. We found a large
range of polyphenols, specially, caffeic acid derivatives.
Song et al. [15] reported that ethanolic extract of
Korean propolis displays estrogenic activity in estrogen-
dependent MCF-7 cells, recombinant ER-α, yeast estrogen
receptor transcription system and immature female rats
and authors concluded that these effects was initiated
through estrogen receptors. In this study, EEP induced a
weak estrogenic activity in vitro by increasing the MCF-7
cells yield but, it did not induce transactivation of reporter
gene activity at all tested doses in both HEK293T ER-α
and ER-β cell systems used in this work. However, it
seems to possess antiestrogenic activity when increasing
concentrations. These results can be explained by the
presence in EEP of caffeic acid derivatives, since caffeic
acid phenethyl ester (CAPE), an abundant phenolic ester
in propolis is well known to exhibit estrogenic activity. In-
deed, Jung et al. [16] demonstrated that CAPE is respon-
sible for, among others, of the estrogenic/antiestrogenic
effects of propolis. They showed that CAPE is a selective
agonist to ER-β, which does not show any estrogenic ef-
fect on estrogen receptor-positive breast cancer cells and
in immature rat uterine tissue. For these reasons authors
claim that CAPE is a potential modulator of the estrogen
receptor [16]. Due to the fact that chemical composition
of propolis is highly variable mainly due to the variability
of plant species growing around the hive [12], the different
amount of caffeic acid derivatives in Cameroonian prop-
olis that in Korean propolis can account for its antagonist
effects observed in vitro at the tested doses. It has been re-
ported that CAPE preferentially binds to ERβ and that
ERβ isoform is involved in anti-proliferative mechanisms
[41]. Chemical composition of propolis greatly varies
A B
C D
Fig. 7 Effects of a 3-day treatment with EEP on mean core temperature (a & b) and core temperature changes (c & d). SHAM= Sham operated
rats treated with the vehicle; OVX =OVX animals treated with the vehicle; E2V = OVX animals treated with estradiol valerate at 1 mg/kg BW; GEN =OVX
animals treated with genistein at 10 mg/kg BW; PRO =OVX animals treated with EEP at doses of 50, 150 and 300 mg/kg BW. * p < 0.05, ** p < 0.01 as
compared to control. # p < 0.05 as compared to Sham. T = treatment. The red line depicts the normal core temperature and variation of core
temperature in rat
Table 4 Effects of EPP on core temperature changes (Δ)
Groups Mean Δ Core
temperature (°C)
Max Δ Core
temperature (°C)
Sham 1.22 ± 0.13 1.63 ± 0.23
OVX 1.5 ± 0.15 # 2.07 ± 0.10 #
E2V 1.1 ± 0.15** 1.71 ± 0.21 *
GEN 1.23 ± 0.12* 1.59 ± 0.17 *
Propolis 50 1.35 ± 0.13 1.60 ± 0.16
Propolis 150 1.09 ± 0.10** 1.40 ± 0.32 **
Propolis 300 1.27 ± 0.12 1.55 ± 0.21*
* p < 0.05, ** p < 0.01 as compared to OVX control. # p < 0.05, ## p < 0.01 as
compared to Sham
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according to the plants that can be found in a spe-
cific region [18, 19]. The caffeic acid derivatives has
been detected as potential estrogenic components in
Cameroonian and Korean propolis, while Okamoto et
al. [42] attributed the estrogenic effects of Brazilian
propolis to the well-known phytoestrogens Kaempferol,
quercetin, naringenin, Biochanin A and formononetin.
These aforesaid suggest a regional difference in estrogenic
components of propolis.
In this study, ovariectomy induced a decrease of uter-
ine wet weight, uterine and vaginal epithelial height and
atrophy of mammary gland. Moreover, it also induced a
significantly increase of the number, duration and fre-
quency of hot flushes in ovariectomized rats (OVX) as
compared to normal animals (SHAM). As expected, a 3-
day consecutive treatment with E2V at the optimal dose
of 1 mg/kg and genistein at the dose of 10 mg/kg
significantly reversed atrophy in estrogen target organs
(uterine, vagina and mammary gland) and hot flushes
observed after ovariectomy. EEP induced a significant
increase of uterine wet weight, uterine total protein
level, uterine and vaginal epithelial height, mammary
gland acini and eosinophil secretion in acini in the bell
shaped diagram with the maximum effect at the dose of
150 mg/kg. These results are interesting because the
growth-stimulatory effect of EEP at the dose of 150 mg/kg
reported in this work is comparable to results of a well
characterized phytoestrogen genistein (10 mg/kg), sug-
gesting that purification of the active principle of EEP
could increase its activity. Additionally the bell shape dia-
gram observed in nearly all assessed parameters suggest a
dose-dependent effect of EEP, which is achieved at
the optimal dose (150 mg/kg) and probably decreased
due to a phenomenon known as “down regulation” of
ERs induced by the high dose. As mentioned above,
EEP contains phenolic compounds that are known to
stimulate uterine growth, uterine and vaginal epithe-
lial height and mammary gland differentiation in a
short-term animal studies [43].
Phenolic compounds contained in EEP might bind to
ERs in vivo and modulate the expression of many genes,
which can account for the increase in total protein level
in uterine, marker of uterine cell proliferation [30, 44].
The increase of protein level in the uterus can induce
uterine water imbibition as suggested by some authors
[44, 45], hence uterine wet weight increases. It is well
know that the removal of endogenous estrogen by ovariec-
tomy results in regression of the mammary gland, and that
estrogen-like substances reverse this regression [30, 46].
Although the complete pathophysiology of hot flushes is
not yet completely understood, their occurrence is as-
sumed to originate in disturbances of the thermo regula-
tory processes in the hypothalamus, which acts as the
body’s thermostat [2]. Fluctuation or decline of the free
fraction of estrogen levels is associated with the initiation
of thermoregulatory dysfunction in women [47]. It was re-
ported that alleviation of hot flushes in women and in rats
both require chronic treatment with estrogen (up to a
month in women and 3–4 days in rats), suggesting that
the action of estrogen is indirect and may involve a cas-
cade in gene expression events including the expression
of neurotransmitters and neuropeptides participating in
thermoregulation such as serotonin [2]. After 3-day
treatment, EEP phenolic compounds significantly de-
creased the number, the duration and the frequency of
hot flushes probably by an ER-dependent mechanism
as mentioned above.
In this study, EEP exhibited estrogen-like activity in
vivo but seems to be antiestrogenic in vitro. Phytoestro-
gens is known to have mixed estrogen agonist/antagonist
properties which are clinically useful [46]. The fact that
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Fig. 8 Effects of a 3-day treatment with EEP on total number (a) and
average duration (b) of hot flushes. SHAM = Sham operated rats
treated with the vehicle; OVX = OVX animals treated with the vehicle;
E2V = OVX animals treated with estradiol valerate at 1 mg/kg BW;
GEN =OVX animals treated with genistein at 10 mg/kg BW; Propolis =
OVX animals treated with EEP at doses of 50, 150 and 300 mg/kg BW. *
p < 0.05, ** p < 0.01 as compared to control. # p < 0.05, ## p < 0.01, ###
p < 0.001 as compared to Sham
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EEP did not induced reporter gene activation in cell
based assay, while it induced an estrogen uterotrophic
response in vivo might either be due the high amount of
active principles that induced “down regulation” of ERs
in HEK293T cells or because active principles of EEP
need some enzymatic transformation to be effective,
given that in vivo assays take into consideration effects
of metabolism, plasma-protein binding and pharmaco-
kinetics [48]. Since a high increase in endometrium
height could be a potential risk of endometrial cancer as
seen in estrogen replacement therapy [49], the weak ef-
fects of EEP in uterine wall can be a safe alternative to
HRT with minimal side effect. Vaginal epithelial prolifer-
ation and cornification observed with EEP treatment are
desired estrogenic effects, because the lactobacillus use
these superficial cells to produce lactic acid, which keeps
the vaginal milieu acidic and thus prevent ascending in-
fections [50]; Moreover, vaginal secretive cells will keep
the vagina wet, thereby avoiding vaginal dryness. The
Combination of therapy with bee venom (0.2 mg) and
bee propolis (0.5 g) was shown to alleviate hot flushes in
85% of treated menopausal women [51]. These observa-
tions concord with part of results obtained with EEP
(150 mg/kg) in hot flushes induced in rats.
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Fig. 9 Effects of a 3-day treatment with standard drugs (a) and EEP (b) on frequency of hot flushes. SHAM = Sham operated rats treated with the
vehicle; OVX = OVX animals treated with the vehicle; E2V = OVX animals treated with estradiol valerate at 1 mg/kg BW; GEN = OVX animals treated
with genistein at 10 mg/kg BW; PRO = OVX animals treated with EEP at doses of 50, 150 and 300 mg/kg BW. * p < 0.05, ** p < 0.01 as compared
to control. # p < 0.05, ## p < 0.01 as compared to Sham
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Conclusion
A universal standardization of propolis would be difficult
because propolis biological actions should be linked to
its chemical composition and plant sources. Ethanol ex-
tracted Cameroonian propolis has now been proven to
possess estrogenic-like effects in rat. Knowing that estro-
genic properties observed in estrogen-deficient animals
following administration of plant preparations are asso-
ciated to phytoestrogens actions, these results suggest
that phenolic compounds detected in Cameroonian
propolis may be a potential source of phytoestrogens.
This might lead to its possible development as an im-
proved traditional medicine for the alleviation of post-
menopausal complaints following further investigation.
Abbreviations
ACN: Acetonitrile; APPI: Atmospheric Pressure Photo Ionisation; BPI: Base
peak intensity; CAPE: Caffeic acid phenethyl ester; DMEM: Dulbecco’s modified
eagle’s medium; E2V: Estradiol valerate; EC: Elemental compositions;
EEP: Ethanolic extract of Cameroonian propolis; ER: Estrogen receptor;
ERE: Estrogen receptor element; ERα: Estrogen receptor alpha; ERβ: Estrogen
receptor beta; ESI: Electrospray ionization; FA: Formic acid; FBS: Fetal bovine
serum; FCS: Fetal calf serum; GC: Gas chromatography; HEK293T: Human
Embryonic Kidney 233 T cells; HRMS: High-resolution Mass Spectrometry;
HRT: Hormone Replacement Therapy; MS: Mass Spectroscopy; ONPG: O-
nitrophenyl-β-galactopyranoside; OVX: Bilaterally ovariectomized rats;
PRO: PROMAX-C; RDBeq: Ring Double Bond Equivalent; RPMI: Roswell Park
Memorial Institute; Rt: Retention time; Sham: Sham operated animals;
SEM: Standard Error of Mean; SRB: Sulforhodamine-B; UPLC: Ultra Performance
Liquid Chromatography
Acknowledgment
The authors are really thankful to the German Academic Exchange Service
(DAAD) and the Alexander von Humboldt Foundation for support. The
authors would also kindly thanks the European Research Institute in Natural
Ingredients (ERINI, Grasse, France) for the use of the high resolution mass
spectrometer.
Funding
The authors declare that they have not received any funding for this work.
Availability of data and materials
The data and materials used in this study are available upon request from
the authors.
Authors’ contributions
ZS and ND design the study. ZS and TJ performed the in vivo part of the
study. MNCB, ZS and CC performed the in vitro part of the study. TM, NTD
and FX performed the phytochemical analysis of the study. FTFN and AM
provided propolis sample. All authors have revised and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Housing of animals and all experiments were approved by the Cameroon
Institutional National Ethic Committee, which adopted all procedures
recommended by the European Union on the protection of animals used for
scientific purposes.
Author details
1Laboratory of Physiology and Natural Products Research, Department of Life
and Earth Sciences, Higher Teachers’ Training College, University of Maroua,
P.O. Box 55, Maroua, Cameroon. 2Laboratory of Animal Physiology,
Department of Animal Biology and Physiology, Faculty of Science, University
of Yaounde 1, P.O. Box 812, Yaoundé, Cameroon. 3Hudson Institute of
Medical Research, 27-31 Wright Street, Clayton, VIC 3168, Australia. 4Institute
of Chemistry of Nice, Faculty of Science, University Côte d’Azur, UMR CNRS
7272, Valrose Park, Nice, France. 5Department of Applied Chemistry, Faculty
of Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein 2028,
South Africa. 6Department of Biological Sciences, Faculty of Science,
University of Ngaoundere, P.O. Box 454, Ngaoundere, Cameroon.
Received: 25 June 2016 Accepted: 7 January 2017
References
1. Dennerstein L. Well-being, symptoms and the menopausal transition.
Maturitas. 1996;23:147–57.
2. Freeman EW, Sammel MD, Sanders RJ. Risk of long-term hot flashes after
natural menopause: evidence from the penn ovarian aging study cohort.
Menopause. 2014;21:924–32.
3. Orleans RJ, Li L, Kim M-J, Guo J, Sobhan M, Soule L, Joffe HV. FDA approval
of paroxetine for menopausal hot flushes. N Engl J Med. 2014;370:1777–9.
4. Birge SJ. Is there a role for estrogen replacement therapy in the prevention
and treatment of dementia? J Am Geriatr Soc. 1996;44:865–70.
5. Burger H. Hormone replacement therapy in the post-Women’s health
initiative era. Report of a meeting held in funchal, Madeira. Climacteric.
2003;6:11–36.
6. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick
ML. Writing group for the Women’s health initiative investigators: risks and
benefits of estrogen plus progestin in healthy postmenopausal women:
principal results from the Women’s health initiative randomized controlled
trial. JAMA. 2002;288:321–33.
7. Dietland M-S. Chemical ecology of vertebrates. Cambridge: Cambridge
University Press; 2006. p. 287.
8. Pitkin J. Alternative and complementary therapies for menopause. Menop
Inter. 2012;18:20–7.
9. Ososki AL, Kennelly EJ. Phyoestrogens: a review of present state of research.
Phytother Res. 2003;17:845–69.
10. Djiogue S, Halabalaki M, Njamen D, Kretzschmar G, Lambrinidis G, Hoepping
J, Raffaelli FM, Mikros E, Skaltsounis AL, Vollmer G. Erythroidine alkaloids: a
novel class of phytoestrogens. Planta Med. 2014;80:861–9.
11. Chearskul S, Kooptiwut S, Chatchawalvanit S, Onreabroi S, Churintrapun M,
Saralamp P, Soonthornchareonnon N. Morinda citrifolia has very weak
estrogenic activity in vivo. Thai Journal of Physiological Sciences. 2004;17:22–9.
12. Trusheva B, Todorov I, Ninova M, Najdenski H, Daneshmand A, Bankova V.
Antibacterial mono- and sesquiterpene esters of benzoic acids from Iranian
propolis. Chem Cent J. 2010;4:8. doi:10.1186/1752-153X-4-8.
13. Popova MP, Chinou IB, Marekov IN, Bankova VS. Terpenes with antimicrobial
activity from Cretan propolis. Phytochemistry. 2009;70:1262–71.
14. Kalogeropoulos N, Konteles SJ, Troullidou E, Mourtzinos I, Karathanos VT.
Chemical composition, antioxidant activity and antimicrobial properties of
propolis extracts from Greece and Cyprus. Food Chem. 2009;116:452–61.
15. Song YS, Jin C, Jung KJ, Park E-H. Estrogenic effects of ethanol and ether
extracts of propolis. J Ethnopharmacol. 2002;82:89–95.
16. Jung BI, Kim M-S, Kim H-A, Kim D, Yang J, Her S, Song HS. Caffeic acid
phenethyl ester, a component of beehive propolis, is a novel selective
estrogen receptor modulator. Phytother Res. 2010;24:295–300.
17. Trusheva B, Popova M, Bankova V, Tsvetkova I, Naydensky C, Sabatini AG. A
new type of European propolis, containing bioactive labdanes. Riv Ital
EPPOS. 2003;36:3–7.
18. Ahn MRS, Kumazawa YUJ, Nakamura M, Matsuka FZ, Nakayama T.
Antioxidant activity and constituents of propolis collected in various areas
of China. Food Chem. 2007;101:1383–92.
19. Popova M, Silici S, Kaftanoglu O, Bankova V. Antibacterial activity of Turkish
propolis and its qualitative and quantitative chemical composition.
Phytomedicine. 2005;12:221–8.
20. Castaldo S, Capasso F. Propolis, an old remedy used in modern medicine.
Fitoterapia. 2002;73:1–6.
21. Mbawala A, Tchuenguem Fohouo F-N, Djoulde R, Milliere J-B. Spectra of
antibacterial activity of propolis (PROMAX-C) samples from two localities of
Adamawa province (Cameroon). Res J Microbiol. 2009;4:150–7.
Zingue et al. BMC Complementary and Alternative Medicine  (2017) 17:65 Page 16 of 17
22. Ingram V, Njikeu J. Sweet, sticky, and sustainable social business. Ecol Soc.
2011;16:37–55.
23. Njintang YN, Tatsadjieu NL, Ngakou A, Danra D, Tchuenguem Fohouo F-N.
Antiradical activity and polyphenol content of ethanolic extracts of Propolis.
Int J Biosci. 2012;2:56–63.
24. Mbawala A, Roger D, Tchuenguem Fohouo F-N, Milliere JB. In vitro
susceptibility of some bacteria strains to ethanol extracts of propolis
collected from two different geographic origins in Cameroon. J Food
Technol. 2010;8:217–22.
25. Seidel V, Peyfoon E, Watson DG, Fearnley J. Comparative study of the
antibacterial activity of propolis from different geographical and climatic
zones. Phytother Res. 2008;22:1256–63.
26. Talla E, Dabole B, Taiwe GS, Ngo Bum T, Mbafor JT, Atchade ADT, Malik R,
Zulfiqar A, Sidiki N, Nguimbou RM, Choudhary MI. Antinociceptive
Pentacyclic Triterpenoids from the Cameroonian Brown Propolis.
Pharmacologia. 2013;4:218–27.
27. Sakava P, Talla E, Chelea M, Tchinda TA, Zeuko’o ME, Laurent S, Vander EL,
Tagatsing FM, Yaya GAJ, Atchade DTA, Mbafor TJ. Pentacyclic triterpenes
and crude extracts with antimicrobial activity from Cameroonian brown
propolis samples. J Appl Pharm Sci. 2014;4:001–9.
28. Resende FA, De Oliveira APS, De Camargo MS, Vilegas W, Varanda EA.
Evaluation of estrogenic potential of flavonoids using a recombinant yeast
strain and MCF7/BUS cell proliferation assay. PLoS ONE. 2013;8:74881.
29. Schiliro´ T, Gorrasi I, Longo A, Coluccia S, Gilli G. Endocrine disrupting
activity in fruits and vegetables evaluated with the E-screen assay in relation
to pesticide residues. J Steroid Biochem Mol Biol. 2011;127:139–46.
30. Zingue S, Michel T, Tchatchou J, Magne Nde CB, Winter E, Monchot A,
Awounfack CF, Djiogue S, Clyne C, Fernandez X, Creczynski-Pasa TB, Njamen
D. Estrogenic effects of Ficus umbellata Vahl. (Moraceae) extracts and their
ability to alleviate some menopausal symptoms induced by ovariectomy in
Wistar rats. J Ethnopharmacol. 2016;179:332–44.
31. Maswood N, Cosmi S, Alfinito PD, Leventhal L, Deecher DC. The role of the
selective serotonin reuptake inhibitor fluoxetine in temperature regulation
in ovariectomized Rat models. Neuroendocrinology. 2006;84:330–8.
32. Gonal AG, Bardwill GS, David MM. Determination of serum proteins by the
means of biuret reactions. J Biol Chem. 1949;177:751–66.
33. Righi AA, Negri G, Salatino A. Comparative Chemistry of Propolis from Eight
Brazilian Localities. J Evid Based Complementary Altern Med. 2013;2013:1–14.
34. Zhanga T, Omara R, Siheria W, Al Mutairia S, Clementsa C, Fearnley J,
Edrada-Ebela RA, Watsona D. Chromatographic analysis with different
detectors in the chemical characterisation and dereplication of African
propolis. Talanta. 2014;120:181–90.
35. Qiao X, Song W, Wang Q, Liu K, Zhang Z-X, Bo T, Li R-Y, Liang L-N, Tzeng Y-
M, Guo D-A, Ye M. Comprehensive chemical analysis of triterpenoids and
polysaccharides in the medicinal mushroom Antrodia cinnamomea. RSC
Adv. 2015;5:47040–52.
36. Riffault L, Colas C, Destandau E, Pasquier L, André P, Elfakir C. Non-targeted
molecular characterisation of a rose flower ethyl acetate extract using Ultra-
HPLC with atmospheric pressure photoionisation and quadrupole time-of-
flight MS/MS. Phytochem Anal. 2015;26:189–201.
37. Kardar MN, Zhang T, Coxon GD, Watson DG, Fearnley J, Seidel V.
Characterisation of triterpenes and new phenolic lipids in Cameroonian
propolis. Phytochemistry. 2014;106:156–63.
38. Sanpa S, Popova M, Bankova V, Tunkasiri T, Eitssayeam S, Chantawannakul P.
Antibacterial compounds from propolis of tetragonula laeviceps and
tetrigona melanoleuca (hymenoptera: apidae) from Thailand. PLoS One.
2015;10:1–11.
39. Li F, Awale S, Zhang H, Tezuka Y, Esumi H, Kadota S. Chemical constituents
of propolis from Myanmar and their preferential cytotoxicity against a
human pancreatic cancer cell line. J Nat Prod. 2009;72:1283–7.
40. Bankova V. Chemical diversity of propolis and the problem of
standardization. J Ethnopharmacol. 2005;100:114–7.
41. Matthews J, Wihlen B, Tujague M, Wan J, Strom A, Gustafsson JÅ. Estrogen
receptor (ER) beta modulates ER-alpha-mediated transcriptional activation
by altering the recruitment of c-Fos and c-Jun to estrogen-responsive
promoters. J Mol Endocrinol. 2006;20:534–43.
42. Okamoto Y, Tobe T, Ueda K, Takada T, Kojima N. Oral administration of
Brazilian propolis exerts estrogenic effect in ovariectomized rats. J Toxicol
Sci. 2015;40:235–42.
43. Diel P, Geis RB, Caldarelli A, Schmidt S, Leschowsky UL, Voss A, Vollmer G.
The differential ability of the phytoestrogen genistein and of estradiol to
induce uterine weight and proliferation in the rat is associated with a
substance specific modulation of uterine gene expression. Mol Cell
Endocrinol. 2004;221:21–32.
44. Hewitt SC, Korach KS. Estrogen receptor knockout mice: roles for estrogen
receptors alpha and beta in reproductive tissues. Reproduction. 2003;125:
143–9.
45. Elbassuoni E, Ragy M, Aziz N. Protective effect of GHRP-6 and estrogen
supplementation against some cardiometabolic risk factors in
ovariectomized rats. Endocr Regul. 2012;46:73–81.
46. Santell RC, Chang YC, Nair MG, Helferich WG. Dietary genistein exerts
estrogenic effects upon the uterus, mammary gland and the hypothalamic/
pituitary axis in rats. J Nutr Educ. 1997;127:263–9.
47. Erlik Y, Meldrum DR, Judd HL. Estrogen levels in postmenopausal women
with hot flashes. Obstet Gynecol. 1982;59:403–7.
48. Andersen HR, Andersson AM, Arnold SF, Autrup H, Barfoed M, Beresford NA,
Bjerregaard P, Christiansen LB, Gissel B, Hummel R, Jorgensen EB, Korsgaard
B, Le Guevel R, Leffers H, McLachlan J, Moller A, Nielsen JB, Olea N, Oles-
Karasko A, Pakdel F, Pedersen KL, Perez P, Skakke-boek NE, Sonnenschein C,
Soto AM, Sumpter JP. Comparison of short-term estrogenicity tests for
identification ofhormone-disrupting chemicals. Environ Health Persp. 1999;
107:89–108.
49. Ito K. Hormone replacement therapy and cancers: the biological roles of
estrogen and progestin in tumor genesis are different between the
endometrium and breast. TJEM. 2007;212:1–12.
50. Heinemann C, Reid G. Vaginal microbial diversity among postmenopausal
women with and without hormone replacement therapy. Can J Microbiol.
2005;51:777–81.
51. Farid A, Bambi E, Dali E, Essia S. Treatment of menopausal syndrome by
beenom and bee propolis (a new modality). Maturitas. 1997;27:201.
52. Almutairi S, Eapen B, Chundi MS, Akhalil A, Siheri W, Clements C, Fearnley J,
Watsona DG, Edrada-Ebel R. New anti-trypanosomal active prenylated
compounds from African propolis. Phytochem Lett. 2014;10:35–9.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Zingue et al. BMC Complementary and Alternative Medicine  (2017) 17:65 Page 17 of 17
